Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Nature Chemical Biology
|
November 23, 2006
Forward chemical genetic approach identifies new role for GAPDH in insulin signaling
Jaeki Min, Yun Kyung Kim, Patricia G Cipriani, et al.
Science Advances
|
December 3, 2020
BRAF inhibition protects against hearing loss in mice
Matthew A Ingersoll, Emma A Malloy, Lauryn E Caster, et al.
Current Topics in Medicinal Chemistry
|
October 8, 2009
Cancer and virus leads by HTS, chemical design and SEA data mining
Pahk Thepchatri, Jaeki Min, Thota Ganesh, et al.
Plos One
|
June 8, 2012
On the mechanism of action of SJ-172550 in inhibiting the interaction of MDM4 and p53
Michal Bista, David Smithson, Aleksandra Pecak, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2022
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACs
Lisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, et al.
Molecular Cancer Therapeutics
|
November 1, 2022
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo
Barbara Jonchere, Justin Williams, Frederique Zindy, et al.
Journal of Medicinal Chemistry
|
March 17, 2018
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation
Jared T Hammill, Deepak Bhasin, Daniel C Scott, et al.
Nature Communications
|
October 2, 2020
Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases
Seung Wook Yang, Xin Huang, Wenwei Lin, et al.
Journal of Medicinal Chemistry
|
August 10, 2016
Hit-to-Lead Studies for the Antimalarial Tetrahydroisoquinolone Carboxanilides
David M Floyd, Philip Stein, Zheng Wang, et al.
Plos Neglected Tropical Diseases
|
December 30, 2017
Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening
Diana Ortiz, W Armand Guiguemde, Jared T Hammill, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Nature Chemical Biology
|
November 23, 2006
Forward chemical genetic approach identifies new role for GAPDH in insulin signaling
Jaeki Min, Yun Kyung Kim, Patricia G Cipriani, et al.
Science Advances
|
December 3, 2020
BRAF inhibition protects against hearing loss in mice
Matthew A Ingersoll, Emma A Malloy, Lauryn E Caster, et al.
Current Topics in Medicinal Chemistry
|
October 8, 2009
Cancer and virus leads by HTS, chemical design and SEA data mining
Pahk Thepchatri, Jaeki Min, Thota Ganesh, et al.
Plos One
|
June 8, 2012
On the mechanism of action of SJ-172550 in inhibiting the interaction of MDM4 and p53
Michal Bista, David Smithson, Aleksandra Pecak, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2022
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACs
Lisa J Alcock, Yunchao Chang, Jamie A Jarusiewicz, et al.
Molecular Cancer Therapeutics
|
November 1, 2022
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo
Barbara Jonchere, Justin Williams, Frederique Zindy, et al.
Journal of Medicinal Chemistry
|
March 17, 2018
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation
Jared T Hammill, Deepak Bhasin, Daniel C Scott, et al.
Nature Communications
|
October 2, 2020
Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases
Seung Wook Yang, Xin Huang, Wenwei Lin, et al.
Journal of Medicinal Chemistry
|
August 10, 2016
Hit-to-Lead Studies for the Antimalarial Tetrahydroisoquinolone Carboxanilides
David M Floyd, Philip Stein, Zheng Wang, et al.
Plos Neglected Tropical Diseases
|
December 30, 2017
Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening
Diana Ortiz, W Armand Guiguemde, Jared T Hammill, et al.
Page
of 7